Samsara BioCapital’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-405,228
| Closed | -$806K | – | 37 |
|
|
2025
Q1 | $806K | Hold |
405,228
| – | – | 0.14% | 27 |
|
|
2024
Q4 | $1.18M | Sell |
405,228
-135,076
| -25% | -$394K | 0.16% | 32 |
|
|
2024
Q3 | $2.09M | Hold |
540,304
| – | – | 0.4% | 28 |
|
|
2024
Q2 | $2.78M | Hold |
540,304
| – | – | 0.58% | 26 |
|
|
2024
Q1 | $3.78M | Buy |
540,304
+70,000
| +15% | +$490K | 0.59% | 27 |
|
|
2023
Q4 | $4.17M | Hold |
470,304
| – | – | 0.65% | 24 |
|
|
2023
Q3 | $4.49M | Hold |
470,304
| – | – | 1.37% | 21 |
|
|
2023
Q2 | $6.89M | Hold |
470,304
| – | – | 1.21% | 17 |
|
|
2023
Q1 | $5.78M | Hold |
470,304
| – | – | 1.2% | 19 |
|
|
2022
Q4 | $8.74M | Buy |
+470,304
| New | +$8.74M | 1.88% | 14 |
|